Precision oncology: Computational methods for multi-omics data integration to improve drug response prediction

Guna Gouru1

  • 1Department of Health Sciences, Northeastern University - Boston Campus, Boston, MA, USA.

Insights

Integrating multi-omics data improves cancer drug response prediction (DRP) for personalized medicine. This review explores computational methods and challenges in using diverse omics data to predict treatment effectiveness.

Area of Science:

  • Computational biology
  • Genomics
  • Precision medicine

Background:

  • Cancer heterogeneity complicates drug treatment, necessitating personalized approaches.
  • Multi-omics data integration advances precision medicine by enhancing tumor biology understanding.
  • Integrating diverse omics data presents computational challenges for traditional methods.

Purpose of the Study:

  • To review studies integrating multi-omics datasets for improved drug response prediction (DRP).
  • To outline common omics types and computational approaches for DRP.
  • To summarize challenges and future directions in multi-omics DRP.

Main Methods:

  • Review of studies integrating multi-omics data for DRP.
  • Categorization of omics types (e.g., genomics, transcriptomics).
  • Analysis of computational approaches: classical machine learning (ML), deep learning, and multimodal integration frameworks.

Main Results:

  • Identified key omics types and computational methods used in DRP.
  • Detailed methodologies and evaluation metrics (e.g., AUC, F1 score, MSE).
  • Summarized challenges in integrating high-dimensional, multimodal data.

Conclusions:

  • Multi-omics data integration is crucial for advancing DRP in precision medicine.
  • Advanced computational models are needed to handle complex omics data.
  • Further research is required to overcome integration challenges and improve predictive accuracy.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.7K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
893